Relypsa logo

Relypsa

ID: 5290413

A biopharmaceutical company developing drugs to treat cardiovascular and renal diseases

4

Funding Rounds

$178.0m

Money raised

Overview

A biopharmaceutical company developing drugs to treat cardiovascular and renal diseases

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Relypsa has raised a total of $178m in funding over 4 rounds.

Key Insights:

  • Relypsa funding round, October 2012: $2.6m
  • Relypsa Series C round: $80m
  • Relypsa funding round, July 2012: $62.4m
  • Relypsa Series A round: $33m

Industries

Relypsa is active in the following industries: